Other Species / Isoforms
  Fe65 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K48-ub
QATAVGPkDLRSAMG
0 3
Fe65 (human) QATAVGPkDLRSAMG K48-ub
Fe65 iso2 (human) QATAVGPKDLRSAMG K48
Fe65 (mouse) QATAVVPkDLRSAMG K48-ub
Fe65 (rat) QATAVVPKDLRSAMG K48
T82-p
NQLRRAAtAHRDQNR
0 1
Fe65 (human) NQLRRAAtAHRDQNR T82-p
Fe65 iso2 (human) NQLRRAATAHRDQNR T82
Fe65 (mouse) NQLRRAATAHRDQNR T82
Fe65 (rat) NQLRRAATAHRDQNR T82
S118-p
KGLIHLYsELELSAH
0 2
Fe65 (human) KGLIHLYsELELSAH S118-p
Fe65 iso2 (human) KGLIHLYSELELSAH S118
Fe65 (mouse) KGLMHLYSELELSAH S118
Fe65 (rat) KGLMHLYSELELSAH S118
P135
ANRGLRGPGLIISTQ
0 1
Fe65 (human) ANRGLRGPGLIISTQ P135
Fe65 iso2 (human) ANRGLRGPGLIISTQ P135
Fe65 (mouse) ANRGLHGsALIINTQ S135-p
Fe65 (rat) ANRGLHGSALIINTQ S135
S175-p
EEEEDLSsPPGLPEP
Upstream
1 1
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK2 (human)
Treatment
  • phorbol_ester
  • U0126
Fe65 (human) EEEEDLSsPPGLPEP S175-p
Fe65 iso2 (human) EEEEDLSSPPGLPEP S175
Fe65 (mouse) EEEEDLSSPPGLPEP S175
Fe65 (rat) EEEEDLSSPQGLPEP S176
K204-ac
DGPREHSksAsLLFG
Downstream
1 0
Effects on Biological Processes:
  • transcription, induced
Fe65 (human) DGPREHSksAsLLFG K204-ac
Fe65 iso2 (human) DGPREHSKSASLLFG K204
Fe65 (mouse) DGPREHSKsAsLLFG K204
Fe65 (rat) DGPREHSKSASLLFG K205
S205-p
GPREHSksAsLLFGM
0 3
Fe65 (human) GPREHSksAsLLFGM S205-p
Fe65 iso2 (human) GPREHSKSASLLFGM S205
Fe65 (mouse) GPREHSKsAsLLFGM S205-p
Fe65 (rat) GPREHSKSASLLFGM S206
S207-p
REHSksAsLLFGMRN
0 2
Fe65 (human) REHSksAsLLFGMRN S207-p
Fe65 iso2 (human) REHSKSASLLFGMRN S207
Fe65 (mouse) REHSKsAsLLFGMRN S207-p
Fe65 (rat) REHSKSASLLFGMRN S208
S228-p
DSSWATLsQGSPSYG
Upstream
Downstream
2 0
Effects on Biological Processes:
  • transcription, inhibited
Putative in vivo kinases:
  • ATM (human)
  • ATR (human)
Treatment
  • AZ20
  • ionizing_radiation
  • KU-55933
  • UV
Fe65 (human) DSSWATLsQGSPSYG S228-p
Fe65 iso2 (human) DSSWATLSQGSPSYG S228
Fe65 (mouse) DSSWATLSQGSPSYG S228
Fe65 (rat) DSSWATLSQGSPSYG S229
S287-p
WEPPGRAsPsQGSSP
Upstream
1 1
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK2 (human)
Treatment
  • phorbol_ester
  • U0126
Fe65 (human) WEPPGRAsPsQGSSP S287-p
Fe65 iso2 (human) WEPPGRASPSQGSSP S287
Fe65 (mouse) WEPPGRASPSQGSSP S287
Fe65 (rat) WEPPGRASPSQGNSP S288
S289-p
PPGRAsPsQGSSPQE
Upstream
1 0
Treatment
  • AZ20
  • KU-55933
  • UV
Fe65 (human) PPGRAsPsQGSSPQE S289-p
Fe65 iso2 (human) PPGRASPSQGSSPQE S289
Fe65 (mouse) PPGRASPSQGSSPQE S289
Fe65 (rat) PPGRASPSQGNSPQE S290
S347-p
TFPAQSLsPEPLPQE
Upstream
1 4
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK2 (human)
Treatment
  • phorbol_ester
  • U0126
Fe65 (human) TFPAQSLsPEPLPQE S347-p
Fe65 iso2 (human) TFPAQSLSPEPLPQE S347
Fe65 (mouse) SFPAQSLsPEPVPQE S347-p
Fe65 (rat) PFSAQSLSPEPVPQE S348
S459-p
VWGVGRDsGRERDFA
1 1
Fe65 (human) VWGVGRDsGRERDFA S459-p
Fe65 iso2 (human) VWGVGRDSGRDFAYV S459
Fe65 (mouse) VWGVGRDsGSNRDFA S459-p
Fe65 (rat) VWGVGRDSGRERDFA S460
K478-ub
DKLTQMLkCHVFRCE
0 1
Fe65 (human) DKLTQMLkCHVFRCE K478-ub
Fe65 iso2 (human) DKLTQMLKCHVFRCE K476
Fe65 (mouse) DKLTQMLKCHVFRCE K478
Fe65 (rat) DKLTQMLKCHVFRCE K479
S517-p
RCLVNGLsLDHSkLV
Upstream
0 6
Treatment
  • ischemia
Fe65 (human) RCLVNGLsLDHSkLV S517-p
Fe65 iso2 (human) RCLVNGLSLDHSKLV S515
Fe65 (mouse) RCLVNGLsLDHSKLV S517-p
Fe65 (rat) RCLVNGLSLDHSKLV S518
K522-ub
GLsLDHSkLVDVPFQ
0 1
Fe65 (human) GLsLDHSkLVDVPFQ K522-ub
Fe65 iso2 (human) GLSLDHSKLVDVPFQ K520
Fe65 (mouse) GLsLDHSKLVDVPFQ K522
Fe65 (rat) GLSLDHSKLVDVPFQ K523
Y547-p
VQKFQVYyLGNVPVA
Downstream
2 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, induced
Fe65 (human) VQKFQVYyLGNVPVA Y547-p
Fe65 iso2 (human) VQKFQVYYLGNVPVA Y545
Fe65 (mouse) VQKFQVYyLGNVPVA Y547-p
Fe65 (rat) VQKFQVYYLGNVPVA Y548
T579-p
SSSREQWtPSHVSVA
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein conformation
Kinase, in vitro:
  • GSK3B (human)
Putative in vivo kinases:
  • GSK3B (human)
Fe65 (human) SSSREQWtPSHVSVA T579-p
Fe65 iso2 (human) SSSREQWTPSHVSVA T577
Fe65 (mouse) SSSREQWTPSHVSVA T579
Fe65 (rat) SSSREQWTPSHVSVA T580
S610-p
ECRVRFLsFLAVGRD
Upstream
Downstream
2 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein conformation
Kinase, in vitro:
  • SGK1 (human)
Fe65 (human) ECRVRFLsFLAVGRD S610-p
Fe65 iso2 (human) ECRVRFLSFLAVGRD S608
Fe65 (mouse) ECRVRFLSFLAVGRD S610
Fe65 (rat) ECRVRFLsFLAVGRD S611-p
K660-ub
ACMLRYQkCLDARSQ
0 1
Fe65 (human) ACMLRYQkCLDARSQ K660-ub
Fe65 iso2 (human) ACMLRYQKCLDARSQ K658
Fe65 (mouse) ACMLRYQKCLDARsQ K660
Fe65 (rat) ACMLRYQKCLDARSQ K661
S666
QkCLDARSQASTSCL
0 1
Fe65 (human) QkCLDARSQASTSCL S666
Fe65 iso2 (human) QKCLDARSQASTSCL S664
Fe65 (mouse) QKCLDARsQTSTSCL S666-gl
Fe65 (rat) QKCLDARSQTSTSCL S667
S695-p
TVRRGVQsLWGsLkP
0 1
Fe65 (human) TVRRGVQsLWGsLkP S695-p
Fe65 iso2 (human) TVRRGVQSLWGSLKP S693
Fe65 (mouse) TVRRGVQSLWGsLKP S695
Fe65 (rat) TVRRGVQSLWGSLKP S696
S699-p
GVQsLWGsLkPKRLG
0 3
Fe65 (human) GVQsLWGsLkPKRLG S699-p
Fe65 iso2 (human) GVQSLWGSLKPKRLG S697
Fe65 (mouse) GVQSLWGsLKPKRLG S699-p
Fe65 (rat) GVQSLWGSLKPKRLG S700
K701-ac
QsLWGsLkPKRLGAH
Downstream
1 0
Effects on Biological Processes:
  • transcription, induced
Fe65 (human) QsLWGsLkPKRLGAH K701-ac
Fe65 iso2 (human) QSLWGSLKPKRLGAH K699
Fe65 (mouse) QSLWGsLKPKRLGSQ K701
Fe65 (rat) QSLWGSLKPKRLGSQ K702
T709-p
PKRLGAHtP______
Upstream
1 7
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • ERK2 (human)
Treatment
  • ischemia
  • phorbol_ester
  • U0126
Fe65 (human) PKRLGAHtP______ T709-p
Fe65 iso2 (human) PKRLGAHTP______ T707
Fe65 (mouse) PKRLGSQtP______ T709-p
Fe65 (rat) PKRLGSQtP______ T710-p